Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Inactivated Mycobacterium obuense (1 trial)
Colorectal Neoplasms (Phase 2)
Necrosis (Phase 2)
Trials (1 total)
Trial APIs (1 total)